1 Report Prologue 9
2 Market Introduction 12
2.1 Specification of Dermal Fillers 12
2.1.1 Hyaluronic Acid 12
2.1.2 Botulinum Toxin 12
2.1.3 Collagen 13
2.1.4 Polymers and Particles 13
2.2 Scope of Study 14
2.2.1 Research Objective 14
2.2.2 Assumptions & Limitations 14
2.2.2.1 Assumptions 14
2.2.2.2 Limitations 14
2.3 Market structure 15
3 Research Methodology 16
3.1 Primary Research 17
3.2 Secondary research 17
3.3 Market Size Estimation 17
4 Market Dynamics 19
4.1 Drivers 19
4.1.1 Growing Demand for Facial Aesthetics Globally 19
4.1.2 Increasing Acceptance of Tissue Fillers And Growing Number Of Dermal Filler Surgeries 20
4.1.3 Rising Awareness About Combination Therapies 20
4.1.4 Growing Ageing population 21
4.2 Restrains 21
4.2.1 Side Effects Associated With Dermal Fillers 21
4.2.2 Dermal Fillers Black Market and Unregistered Practitioners 22
5 Market Factor Analysis 23
5.1 Porters five Forces 23
5.1.1 Bargaining power of suppliers 24
5.1.2 Bargaining Power Of Buyers 24
5.1.3 Threat Of New Entrants 24
5.1.4 Threat Of Substitutes 24
5.1.5 Intensity of Rivalry 25
5.2 Value Chain Analysis 25
5.2.1 Introduction 25
5.2.1.1 Inputs 25
5.2.1.2 Drug Development 25
5.2.1.3 Manufacturing process of facial injectable 25
5.2.1.4 Marketing and distribution 26
6 Global Dermal Fillers Market By Types 27
6.1 Botulinum Toxin 28
6.2 Hyaluronic Acid 29
6.3 Polymers & Particles 29
6.4 Collagen 30
7 Global Dermal Fillers Market By Application 31
7.1 Facial Line Correction Treatment 32
7.2 Face-Lift 32
7.3 Lip Treatments 33
8 Global Dermal Fillers Market by Regions 34
8.1 Americas 35
8.1.1 North America 37
8.1.1.1 US 38
8.1.1.2 Canada 39
8.1.2 Latin America 41
8.2 Europe 42
8.2.1 Germany 44
8.2.2 France 45
8.2.3 UK 47
8.2.4 Italy 48
8.2.5 Spain 49
8.2.6 Rest of Europe 51
8.3 Asia Pacific 52
8.3.1 China 54
8.3.2 Japan 55
8.3.3 India 57
8.3.4 South Korea 58
8.3.5 Rest of Asia Pacific 59
8.4 Middle East & Africa 61
9 Competitive Landscape 64
9.1 Mergers Acquisitions 64
9.2 Approvals and Product Launches 65
9.3 Others 66
10 Company Profiles 68
10.1 GALDERMA 68
10.1.1 Company Overview 68
10.1.2 Product Overview 68
10.1.3 Financial Overview 69
10.1.4 Key Developments 69
10.2 ALLERGAN 70
10.2.1 Company Overview 70
10.2.2 Product Overview 70
10.2.3 Financial Overview 71
10.2.4 Key Development 72
10.3 Merz Pharma 74
10.3.1 Company Overview 74
10.3.2 Product Overview 74
10.3.3 Financial Overview 75
10.3.4 Key developments 76
10.4 Dr. Korman Laboratories 77
10.4.1 Company Overview 77
10.4.2 Product Overview 77
10.4.3 Financial Overview 78
10.5 Sinclair Pharma 79
10.5.1 Company Overview 79
10.5.2 Product Overview 79
Financial Overview 79
10.5.3 Key Development 80
10.6 Teoxane laboratories 81
10.6.1 Company Overview 81
10.6.2 Product Overview 81
10.6.3 Financial Overview 81
10.7 Integra Lifesciences 82
10.7.1 Company Overview 82
10.7.2 Product Overview 82
10.7.3 Financial Overview 82
10.7.4 Key Developments 84
11 Conclusion 85
11.1 Key Companies to watch 85
12 Appendix 86